Literature DB >> 2403975

Histopathologic analysis of suspected amiodarone hepatotoxicity.

J H Lewis1, F Mullick, K G Ishak, R C Ranard, B Ragsdale, R M Perse, E J Rusnock, A Wolke, S B Benjamin, L B Seeff.   

Abstract

This analysis of the morphology of suspected amiodarone (AD) liver disease is based on a study of liver specimens from 17 individuals. Changes similar to alcoholic liver injury were commonly seen. Steatosis, both macrovesicular and microvesicular, was the most frequent histopathologic feature. Ballooning of hepatocytes, Mallory bodies, and fibrosis were also common. Other changes included nuclear unrest, acidophilic bodies, foam cells, glycogenated nuclei, and portal inflammation. Characteristic lamellar lysosomal inclusion bodies representing phospholipidosis were found in two of 14 specimens studied ultrastructurally. These changes of pseudoalcoholic hepatitis and/or phospholipidosis were present in liver specimens from asymptomatic, anicteric patients with mild elevations in serum aminotransferase or alkaline phosphatase values with or without hepatomegaly, as well as in patients with clinically overt symptoms of hepatotoxicity. Phospholipidosis appears to be a generalized systemic effect of cationic amphophilic compounds, such as AD. The cytotoxic pseudoalcoholic changes appear to be an independent phenomenon in susceptible patients, whom we speculate may have been unable or less able to metabolize AD through normal pathways. The true incidence of hepatic injury from AD remains to be determined from prospective evaluations of pretreatment and follow-up liver biopsies.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2403975     DOI: 10.1016/0046-8177(90)90076-h

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  24 in total

Review 1.  Drug-induced Liver Injury: The Hepatic Pathologist's Approach.

Authors:  David E Kleiner
Journal:  Gastroenterol Clin North Am       Date:  2017-06       Impact factor: 3.806

2.  [Severe intrahepatic cholestasis in a 66-year old male patient with medically treated atrial fibrillation].

Authors:  F Gundling; H L Tillmann; O Schmidt; M Brennenstuhl; A Nerlich; W Schepp
Journal:  Internist (Berl)       Date:  2005-09       Impact factor: 0.743

3.  Liver cirrhosis induced by long-term administration of a daily low dose of amiodarone: a case report.

Authors:  Hiroki Oikawa; Chihaya Maesawa; Ryo Sato; Kanta Oikawa; Hiroyuki Yamada; Seizo Oriso; Sadahide Ono; Akiko Yashima-Abo; Koji Kotani; Kazuyuki Suzuki; Tomoyuki Masuda
Journal:  World J Gastroenterol       Date:  2005-09-14       Impact factor: 5.742

Review 4.  Managing the challenge of drug-induced liver injury: a roadmap for the development and deployment of preclinical predictive models.

Authors:  Richard J Weaver; Eric A Blomme; Amy E Chadwick; Ian M Copple; Helga H J Gerets; Christopher E Goldring; Andre Guillouzo; Philip G Hewitt; Magnus Ingelman-Sundberg; Klaus Gjervig Jensen; Satu Juhila; Ursula Klingmüller; Gilles Labbe; Michael J Liguori; Cerys A Lovatt; Paul Morgan; Dean J Naisbitt; Raymond H H Pieters; Jan Snoeys; Bob van de Water; Dominic P Williams; B Kevin Park
Journal:  Nat Rev Drug Discov       Date:  2019-11-20       Impact factor: 84.694

Review 5.  Drug-induced steatohepatitis.

Authors:  Vaishali Patel; Arun J Sanyal
Journal:  Clin Liver Dis       Date:  2013-09-04       Impact factor: 6.126

6.  Clinicopathologic study of alcohol-like liver disease in non-alcoholics; non-alcoholic steatohepatitis and fibrosis.

Authors:  A Nonomura; Y Mizukami; M Unoura; K Kobayashi; Y Takeda; R Takeda
Journal:  Gastroenterol Jpn       Date:  1992-08

7.  Role of vitamin-E on rat liver-amiodarone: an ultrastructural study.

Authors:  Mohamed Samir A Zaki; Refaat A Eid
Journal:  Saudi J Gastroenterol       Date:  2009-04       Impact factor: 2.485

8.  Interaction with the hERG channel and cytotoxicity of amiodarone and amiodarone analogues.

Authors:  K M Waldhauser; K Brecht; S Hebeisen; H R Ha; D Konrad; D Bur; S Krähenbühl
Journal:  Br J Pharmacol       Date:  2008-07-07       Impact factor: 8.739

9.  Amiodarone-induced hepatitis and polyneuropathy.

Authors:  Hyun Mo Kang; Yoon Sae Kang; Seok Hyun Kim; Jae Kyu Seong; Dae Young Kang; Heon Young Lee; Byung Seok Lee
Journal:  Korean J Intern Med       Date:  2007-09       Impact factor: 2.884

10.  Amiodarone hepatotoxicity with absent phospholipidosis and steatosis: a case report and review of amiodarone toxicity in various organs.

Authors:  Adela Cimic; Joseph Sirintrapun
Journal:  Case Rep Pathol       Date:  2013-05-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.